Article Versions Notes

Roncato R, Angelini J, Pani A, Cecchin E, Sartore-Bianchi A, Siena S, De Mattia E, Scaglione F, Toffoli G. CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions. International Journal of Molecular Sciences. 2020; 21(17):6350. https://doi.org/10.3390/ijms21176350

Roncato, Rossana, Jacopo Angelini, Arianna Pani, Erika Cecchin, Andrea Sartore-Bianchi, Salvatore Siena, Elena De Mattia, Francesco Scaglione, and Giuseppe Toffoli. 2020. "CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions" International Journal of Molecular Sciences 21, no. 17: 6350. https://doi.org/10.3390/ijms21176350

Roncato, R., Angelini, J., Pani, A., Cecchin, E., Sartore-Bianchi, A., Siena, S., De Mattia, E., Scaglione, F., & Toffoli, G. (2020). CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions. International Journal of Molecular Sciences, 21(17), 6350. https://doi.org/10.3390/ijms21176350